VIVUS Inc. (NASDAQ:VVUS) caters to the Healthcare space. It has a net profit margin of -95.80% and weekly performance is 34.45%. On the last day of trading company shares ended up at $1.60. VIVUS Inc. (NASDAQ:VVUS) distance from 50-day simple moving average (SMA50) is 2.77%.
VIVUS, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutic products. It provides two therapies approved by the Food and Drug Association (FDA), which include Qsymia (phentermine and topiramate extended-release) for chronic weight management and STENDRA (avanafil) for erectile dysfunction (ED).
VIVUS, Inc. (NASDAQ:VVUS) has received a buy rating for the short term, according to the latest rank of 2 from research firm, Zacks.
SunCoke Energy Inc. (NYSE:SXC) shares decreased -0.60% in last trading session and ended the day at $9.94. SXC Gross Margin is 19.50% and its has a return on assets of -4.40%. SunCoke Energy Inc. (NYSE:SXC) quarterly performance is -28.03%.
SunCoke Energy, Inc. (SunCoke) is an independent producer of coke, a principal raw material in the blast furnace steelmaking process. The Company operates through four segments: Domestic Coke, Brazil Coke, India Coke and Coal Logistics. The Company’s Domestic Coke consists of its Indiana Harbor, Haverhill, Granite City and Middletown cokemaking and heat recovery operations located in Vansant, Virginia; East Chicago, Indiana; Franklin Furnace, Ohio; Granite City, Illinois, and Middletown, Ohio, respectively.
Analysts at Zacks have given a short term rating of sell on SunCoke Energy, Inc. (NYSE:SXC) with a rank of 4. The shares have received an average rating of 1 from 3 brokerage firms.
DeVry Education Group Inc. (NYSE:DV) ended the last trading day at $26.16. Company weekly volatility is calculated as 2.65% and price to cash ratio as 4.66. DeVry Education Group Inc. (NYSE:DV) showed a weekly performance of 3.93%.
DeVry Education Group Inc. (DeVry Group) is a provider of educational services. DeVry Group’s institutions offer an array of programs in business, healthcare and technology, and serve students in postsecondary education as well as accounting and finance professionals. DeVry Group operates through three segments: Business, Technology and Management, Medical and Healthcare, and International and Professional Education.
DeVry University graduates have the highest federal student loan debt among 29 for-profit colleges in Ohio, according to a higher education database the U.S. Department of Education released Saturday. The department surveyed the median amount of federal debt among graduates at the colleges and their branches — a total of 57 locations in Ohio. The government doesn’t rank the schools, though Northeast Ohio Media Group is ranking schools on several criteria Monday and Tuesday.
Willbros Group Inc. (NYSE:WG) shares decreased -6.85% in last trading session and ended the day at $1.36. WG Gross Margin is 8.30% and its has a return on assets of -10.30%. Willbros Group Inc. (NYSE:WG) quarterly performance is -26.49%.
Willbros Group, Inc. (Willbros) is a specialty energy infrastructure contractor serving the oil, gas, refining, petrochemical and power industries. The Company’s offerings include engineering, procurement and construction (EPC), turnarounds, maintenance, facilities development and operations services.
Willbros Group, Inc. (NYSE: WG) announced that the Company will be attendingD.A. Davidson’s 14th Annual Engineering & Construction Conference to be held in San Francisco on September 10 – 11, 2015. Michael J. Fournier, President and Chief Operating Officer, is scheduled to present on Friday, September 11th at 9:15 a.m. Pacific Time (11:15 a.m. Central Time).
BioTime, Inc. (NYSEMKT:BTX) caters to the Healthcare space. Its weekly performance is 9.94%. On the last day of trading company shares ended up at $3.54. BioTime, Inc. (NYSEMKT:BTX) distance from 50-day simple moving average (SMA50) is 12.66%.
BioTime, Inc. is a biotechnology company. The Company is focused on the field of regenerative medicine; human embryonic stem (hES) cell and induced pluripotent stem (iPS) cell technology. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury.
BioTime, Inc. (NYSE MKT and TASE: BTX) announced that it has agreed to sell 2,607,401 of its common shares, no par value, at an offering price of $3.29 per share, for a gross purchase price of approximately $8.58 million, to selected investors, including a major shareholder, Broadwood Partners, L.P. (“Broadwood”), in a registered direct offering. The price per share was the closing price of BioTime common shares on the NYSE MKT on September 11, 2015, the last trading day before BioTime and the investors entered into an agreement for the sale of the shares.
Leave a Reply